EUCTR2004-003495-11-IT进行中（未招募）不适用
PHASE III STUDY OF CHEMOHORMONAL THERAPY WITH TO DIFFERENT MODALITIES CONCOMITANT OR ALTERNATE VERSUS HORMONAL THERAPY ALONE IN ADVANCED PROSTATE CANCER PATIENTS.
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO0 个研究点目标入组 200 人开始时间: 2007年3月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Phase III study of chemotherapy in combination with ATRA with or without gemtuzumab ozogamicin in patients with acute myeloid leukemia and NPM1 gene mutatioadult patients with AML and NPM1 mutationEUCTR2009-011889-28-ATniversity of Ulm588
进行中（未招募）
1 期
Phase III study of chemotherapy in combination with ATRA with or without gemtuzumab ozogamicin in patients with acute myeloid leukemia and NPM1 gene mutatioEUCTR2009-011889-28-DEniversity of Ulm588
进行中（未招募）
不适用
A Phase III Trial Evaluating the Role of Chemotherapy as Adjuvant Therapy for Premenopausal Women with Endocrine Responsive Breast Cancer Who Receive Endocrine Therapy - Premenopausal Endocrine Responsive Chemotherapy Trial (PERCHE)Premenopausal women with histologically proven, resected breast cancer with ERand/or PgR positive tumors for whom there is an uncertain role for adding chemotherapy to the adjuvant treatment programMedDRA version: 7.0Level: LLTClassification code 10057654EUCTR2005-002626-59-SEInternational Breast Cancer Study Group (IBCSG)1,750
进行中（未招募）
不适用
A Phase III Trial Evaluating the Role of Chemotherapy as Adjuvant Therapy for Premenopausal Women with Endocrine Responsive Breast Cancer Who Receive Endocrine Therapy - Premenopausal Endocrine Responsive Chemotherapy Trial (PERCHE)Premenopausal women with histologically proven, resected breast cancer with ERand/or PgR positive tumors for whom there is an uncertain role for adding chemotherapy to the adjuvant treatment programMedDRA version: 7.0Level: LLTClassification code 10057654EUCTR2005-002626-59-DEGBG Forschung GmbH1,750
进行中（未招募）
1 期
A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as pre-operative treatment for locally recurrent rectal cancer (GRECCAR – PRODIGE – FRENCH) - GRECCAR 15Recurrent rectal cancer after local excision, Rectal cancerMedDRA version: 20.0Level: PTClassification code: 10038038Term: Rectal cancer Class: 100000004864CTIS2024-514705-62-00Centre Hospitalier Universitaire De Bordeaux186